Interstitial alterations in renal cortex in acute tubular necrosis (ATN) post-renal transplantation and in patients with ATN not related to renal transplant

Clinical Transplantation

Volumn 18, Issue 2, 2004, Pages 156-165

  Neto, Miguel Moyses ^a   Costa, Roberto S ^a   Volpini, Rildo A ^a   Garcia, Tânia M P ^a   Rodrigues, Fernanda F ^a   Coimbra, Terezila Machado ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute tubular necrosis; Myofibroblasts; NF B; Renal fibrosis; Renal transplant; Transforming growth factor endothelin

Indexed keywords

ALPHA ACTIN; ENDOTHELIN; FIBRONECTIN; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN ANTIBODY; RIFAMPICIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; MALE; MYOFIBROBLAST; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEINURIA; URINALYSIS;

ACTINS; ADOLESCENT; ADULT; ENDOTHELINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY CORTEX; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; TRANSFORMING GROWTH FACTOR BETA;

EID: 1642565347     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0012.2003.00140.x     Document Type: Article

References (34)

1. Lechevallier E, Dussol B, Luccioni A et al. Post-transplantation acute tubular necrosis: Risk factors and implications for graft survival. Am J Kidney Dis 1998: 32: 984.
2. Cronin RE, Henrich WL. Toxic nephropathy. In: BRENNER BM ed. The Kidney, Philadelphia: Saunders, 2000.
3. Cronin RE, Burger RE, Southern et al. Natural history of aminoglycoside nephrotoxicity in the dog. J Lab Clin Med 1980: 95: 463.
4. Houghton DC, English J, Bennett WM. Chronic tubulointerstitial nephritis and renal insufficiency associated with long-term 'subtherapeutic' gentamicin. J Lab Clin Med 1988: 112: 694.
5. Pagtalunan ME, Olson JL, Tilney NL, Meyer TW. Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 1999: 10: 366.
6. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation-tissue myofibroblasts and quiescent and growing cultured fibroblasts. J Cell Biol 1993: 122: 103.
7. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000: 15: 290.
8. ElNahas AM, Muchaneta-Kubara EC, Zhang G-Z et al. Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int 1996: 49 (Suppl. 54): S23
9. Forbes JM, Leaker B, Hewitson TD et al. Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists. Kidney Int 1999: 55: 198.
10. Roelofs M, Faggian L, Pampinella F et al. Transforming growth factor-beta 1 involvement in the conversion of fibroblasts to smooth muscle cells in the rabbit bladder serosa. Histochem J 1998: 30: 393.
11. Guijarro C, Egido J. Transcription factor-κB (NF-κB) and renal disease. Kidney Int 2001: 59: 415.
12. Massy ZA, Guijarro C, O'Donnel MP et al. The central role of nuclear factor-κB in mesangial cell activation. Kidney Int 1999: 56 (Suppl. 71): S76.
13. Xia Z, Dickens M, Raingeaud J et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995: 270: 1326.
14. Shih W, Hines WH, Neilson EG. Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int 1988: 33: 1113.
15. Baroni EA, Costa RS, Da Silva CGA, Coimbra TM. Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta. Nephron 2000: 84: 248.
16. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhancement expression Af "mUscle-specific" actin in glomerulonephritis. Kidney Int 1992: 41: 1134.
17. Muchaneta Kubara EC, El Nahas AM. Myofibroblast phenotype expression in experimental renal scarring. Nephrol Dial Transpl 1997: 12: 904.
18. Ng YY, Huang TP, Yang WC et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998: 54: 864.
19. Struz F, Muller GA, Neilson EG. Transdifferentiation: A new angle on renal fibrosis. Exp Nephrol 1996: 4: 267.
20. Zhang G, Moorhead PJ, Nahas AM. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995: 3: 308.
21. Geleilete TJ, Costa RS, Dantas M, Coimbra TM. α-Smooth muscle actin and proliferating cell nuclear antigen expression in focal segmental glomerulosclerosis: Functional and structural parameters of renal disease progression. Braz J Med Biol Res 2001: 34: 985.
22. Groma V. Demonstration of collagen type VI and alpha-smooth muscle actin in renal fibrotic injury in man. Nephrol Dial Transplant 1998: 13: 305.
23. Schllöndorff D. The role of chemokines in the initiation and progression of renal disease. Kidney Int 1995: 47 (Suppl. 49): S44
24. Kliem V, Johnson RJ, Alpers CE et al. Mechanism involved in the pathogenesis of tubulonterstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1996: 49: 666.
25. Donnahoo KK, Meldrum DR, Shenkar R et al. Early renal ischemia, with or without reperfusion, activates NF-kB and increases TNF-α bioactivity in the kidney. J Urol 2000: 163: 1328.
26. Hill CS & Triesman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 1995: 80: 199.
27. Geleilete TJ, Melo GC, Volpini RA et al. Role of myofibroblasts, macrophages, transforming growth factor-beta, endothelin, angiotensin II and fibronectin in the evolution of tubulointerstitial nephritis induced by gentamicin. J Nephrol 2002: 15: 633.
28. Brophy D, Najarian JS, Killstrand CM. Acute tubule necrosis after renal transplantation. Transplantation 1980: 29: 245.
29. McLaren AJ, Jassen W, Gray DWR et al. Delayed graft function:rIsk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999: 13: 266.
30. Ojo AO, Wolfe RA, Held PJ et al. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997: 63: 968.
31. Tilney NL, Guttman RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997: 64: 945.
32. Boom H, Mallat MJK, De Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000: 58: 859.
33. Ramaswamy D, Corrigan G, Polhemus C et al. Maintenance and recovery stages of postischemic acute renal failure in humans. Am J Physiol 2002: 282: F271.
34. Gillich MS, Heimbach D, Schoeneich G et al. Comparison of blood group versus HLA-dependent transplantation and its influence on donor kidney survival. Nephrol Dial Transplant 2002: 17: 884.